US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Galera Therapeutics Inc (QB) (GRTX) 銘柄情報

Galera Therapeutics Inc (QB) (GRTX)

0.0861

0.0004

( 0.47% )

更新日時： 23:42:28

Galera Therapeutics Inc (QB) (GRTX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0861

( 0.47% )

買値

0.0861

売値

0.095

出来高

6,417

0.0857 日の範囲 0.08877

0.0151 52 週間の範囲 0.15

時価総額

前日終値

0.0857

始値

0.0857

時刻

最終取引時間

23:42:28

財務取引量

US$ 553

VWAP

0.086226

平均取引量 (3 か月)

US$ 308,624

発行済株式数

160,429,783

配当利回り

PER

0.13

1 株当たり利益 (EPS)

0.64

歳入

-

純利益

149.04M

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat pa... Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC). The company was incorporated in 2012 and is based in Malvern, Pennsylvania. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.galeratx.com

本社

Malvern, United States

設立

2026

Galera Therapeutics Inc (QB) is listed in the Healthcare sector of the その他OTC with ticker GRTX. The last closing price for Galera Therapeutics (QB) was US$0.09. Over the last year, Galera Therapeutics (QB) shares have traded in a share price range of US$ 0.0151 to US$ 0.15.

Galera Therapeutics (QB) currently has 160,429,783 shares in issue. The market capitalisation of Galera Therapeutics (QB) is US$13.81 million. Galera Therapeutics (QB) has a price to earnings ratio (PE ratio) of 0.13.

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.001	1.17508813161	0.0851	0.095	0.084	122876	0.08622405	CS
4	-0.0162	-15.8357771261	0.1023	0.1074	0.0838	62231	0.09206543	CS
12	0.0421	95.6818181818	0.044	0.15	0.041	326097	0.08448308	CS
26	0.0636	282.666666667	0.0225	0.15	0.021	189145	0.07595515	CS
52	0.0591	218.888888889	0.027	0.15	0.0151	142267	0.05729448	CS
156	-0.0447	-34.1743119266	0.1308	0.15	0.0151	194294	0.06877946	CS
260	-0.0447	-34.1743119266	0.1308	0.15	0.0151	194294	0.06877946	CS

GRTX - Frequently Asked Questions (FAQ)

What is the current Galera Therapeutics Inc (QB) share price?

The current share price of Galera Therapeutics Inc (QB) is US$ 0.0861

How many Galera Therapeutics Inc (QB) shares are in issue?

Galera Therapeutics Inc (QB) has 160,429,783 shares in issue

What is the market cap of Galera Therapeutics Inc (QB)?

The market capitalisation of Galera Therapeutics Inc (QB) is USD 13.81M

What is the 1 year trading range for Galera Therapeutics Inc (QB) share price?

Galera Therapeutics Inc (QB) has traded in the range of US$ 0.0151 to US$ 0.15 during the past year

What is the PE ratio of Galera Therapeutics Inc (QB)?

The price to earnings ratio of Galera Therapeutics Inc (QB) is 0.13

What is the registered address of Galera Therapeutics Inc (QB)?

The registered address for Galera Therapeutics Inc (QB) is 101 Lindenwood Drive, Malvern, Pennsylvania, 19355

What is the Galera Therapeutics Inc (QB) website address?

The website address for Galera Therapeutics Inc (QB) is www.galeratx.com

Which industry sector does Galera Therapeutics Inc (QB) operate in?

Galera Therapeutics Inc (QB) operates in the Biotechnology & Life Sciences sector

sab63090

sab63090 39秒前

the shorts are not yet hungry, less than 300K shs traded and a gap below!

I will check back in a few hours......they control the price with the HELP of the market maker....

panman2013

panman2013 40秒前

This "will" trade, because all of the insiders will sell the ill gotten shares until no bid. Then all of the sucker retail buyers will be left holding the bag when that happens. Have you not followed the various shell companies this originated from? It's all a share selling scheme.

MONTI KING

MONTI KING 1分前

Then they probably shouldn’t have it on their website!

Luis Andros

Luis Andros 2分前

You do know you are responding to one of the resident retards here right?? 🙄 They literally live for your reply. 😑

jay14

In matters of intellectual property and corporate governance, a documented paper trail establishing "actual knowledge" completely dismantles defenses based on "good faith" or "blind reliance...."

Kool Aid Man

Kool Aid Man 2分前

Financial volume=$425 so far today...pfffttttt

88TH MAN

88TH MAN 3分前

I don't concern myself with hypotheticals. We are waiting patiently for the future of Xeriant, and all it has to offer. We are holding, and purchasing until it gets too expensive. Bullish!!!

shajandr

shajandr 3分前

Plowboi = 100% loss in this obvious scam. Again (yett again),

Truth and Transparency

Truth and Transparency 3分前

It’s very weird and something Niocorp management has failed to address. It’s also weird that we are at the end of June and still no updated feasibility study, no EXIM news, and no news on the Traxys definitive agreement. I’m beginning to thing Niocorp management has checked out.

keepemcloser

keepemcloser 3分前

Could be someone offering because someone wants a cheap position in open market,no strings?Just a guess.

DTGoody

DTGoody 3分前

I plan on buying another $1,000 worth in about two weeks. Hopefully these prices are still available. I have no problem paying between.007 and .008 while nobody wants these shares. So if you are wanting to sell I plan on buying more in about two weeks.

speakhim

speakhim 3分前

Anyone's guess . Situations like this do not come super quick , Direction of the company was not aligned with the money backers I'm guessing.

Monksdream

Monksdream 4分前

EHGO. there it goes

shajandr

shajandr 4分前

Where can anyone buy the Trump book today?

Bonvoy85

Bonvoy85 4分前

It seems someone very bigly wants this sitting at about 5.20 until perhaps we have actual news.

glenn1919

glenn1919 4分前

EHGO.................................thankyou

bielrocket

bielrocket 4分前

That's definitely a good question! Bobby! Hopefully its for the better with Biel!

JusDePomme

JusDePomme 5分前

TIPS bounce chart

Foogie88

Foogie88 5分前

Either Fish or cut bait, but this NOTHING every day isthe worst. If you cant get it across the goal line in 3 years then just drop the damn application

jimmybob

jimmybob 5分前

Noble Prize Winner in Chemistry going rate is $301 billion and counting

$GOOGL $GOOG

EpicSage

EpicSage 5分前

$VSEE VSee Health reports strong post-sale performance and a renewed focus on its iDoc telehealth platform — driving major revenue growth.

Read more: https://wix.to/7FPgRHr

#VSee #Telehealth #HealthTech

TightCoil

TightCoil 5分前

How much did you have to pay
to read it...$10,000?
Barron's charges a lot,

Boston-Bets

Boston-Bets 5分前

Looks like today is one of the "down to the $13's day". Let's see when we're at the "back to the $14's".

Mr. Dragon

Mr. Dragon 6分前

Expect controlled dumping all day. Its all S-1 Denny knows how to do.

barnstormer

barnstormer 6分前

If you were talking about Spitfire, I've got the vinyl tucked away somewhere.

Galera Therapeutics (QB)

AB Sveriges Sakerstallda...

Grupo Aval Acciones y Va...

Lifestyle Communities

Natixis Structured Issua...

Hsbc Msci Emerging Marke...

Keisei Electric Railway

Deutsche Annington Finan...

Barclays 8%perp

Fidelity Emerging Market...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。